Please assess the completion status of the following clinical trial:

Trial Title: Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* 0-21 years of age with a diagnosis of a immunodeficiency, congenital marrow failure syndrome, inborn error of metabolism, or hereditary anemia~* Appropriately matched related or unrelated umbilical cord blood unit with a cell dose ≥ 3 x 10e7cells/kg~* Performance score (lansky or karnofsky) greater than or equal to 70~* Adequate organ function (Creatinine ≤ 2.0 mg/dl and creatinine clearance ≥ 50 ml/min/1.73 m2; Hepatic transaminases (ALT/AST) ≤ 4 x normal; Shortening fraction \>26% or ejection fraction \>40% or \> 80% of normal value for age; Pulmonary function tests demonstrating CVC or FEV1/FVC of \>60% of predicted for age.)~* Informed consent~* Not pregnant or breast feeding~* Minimum life expectancy of at least 6 months~* HIV negative~* No uncontrolled infections at the time of cytoreduction~* Disease specific inclusion criteria~Exclusion Criteria:~* Patients with hemoglobinopathies \> 3 years of age~* UCB unit with a total nucleated cell count \< 3 x 10e7/kg or \> 2 antigen mismatching~* Available HLA-matched related living donor able to donate without previous UCB donation~* Allogeneic hematopoietic stem cell transplant within the previous 6 months~* Any active malignancy, MDS, or any history of malignancy~* Severe acquired aplastic anemia~* DLCO \< 60% of normal value for age; requirement for supplemental oxygen~* Uncontrolled bacterial, viral or fungal infection (currently taking medication and progression of clinical symptoms)~* Pregnancy or nursing mother~* HIV/HTLV seropositive, Hep B surface antigen positive, or HCV RNA positive by PCR~* Any condition that precludes serial follow-up

- Gender: ALL
- Minimum Age: None
- Maximum Age: 21 Years
- Healthy Volunteers: f

Study Arms:
- RIC Cord Blood Transplant (Type: EXPERIMENTAL): Reduced Intensity Conditioning for Umbilical Cord Blood Transplant

Based on this trial design, predict the completion outcome and termination type (if applicable).